Bambusa Therapeutics, Inc. - 8-K Filing

Bambusa Therapeutics adopts amended certificate of incorporation and bylaws following completion of initial public offering. (Items: 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $BBTX

Read the full article at SEC EDGAR

More Regulatory news